Background and aim. Despite the availability of a vaccine, measles continues to be endemic in Italy, where an increase of cases was reported during 2016. This study describes the measles outbreaks in Emilia-Romagna Region (ERR), one of the Italian regions mostly affected.
Introduction
Measles virus (MV) is responsible for an infectious disease that often can result to serious complications (3, 20) . The World Health Organization (WHO) set the goal to eliminate the indigenous MV transmission in all 53 Member States of the WHO European Region through the European Vaccine Action Plan 2015-2020 (5) . Although progress has been made, 14 countries still remain endemic for measles transmission, including Italy, where many outbreaks have occurred in recent years (1, 19, 21, 26, 27) . During 2016, an increase in the reported measles cases in comparison to those recorded during 2015 (866 versus 259 cases) was observed (28) . Six Italian regions were mostly affected, including the Emilia-Romagna Region (ERR) (28) . In accordance with a national surveillance plan, physicians must report all clinically consistent measles/rubella cases to the Local Health Authorities (LHAs) that perform the epidemiological investigation and obtain specimens to send at designated laboratory for diagnosis and genotyping of MV/Rubella Virus (RV) (11, 19) . In 2010, the Laboratory of Virology, St. Orsola-Malpighi Polyclinic, University of Bologna, was designated by the ERR authorities as Regional Reference Laboratory (LRR) for measles/rubella surveillance and in 2017 was accredited by National Reference Laboratory (NRL) in MoRoNet (Network of the Subnational Reference Laboratories), as LRR01 (18, 21) .
The study describes, through data obtained by an active surveillance system, the measles cases reported in ERR during 2016 focusing on cases reported in Bologna, the main city of the ERR. Moreover, the molecular characterization of MV circulated was performed comparing the strains identified with those detected in Italy and other European countries.
Material and Methods

Study population
From January to December 2016, 101 suspected measles cases were reported in ERR. A total of 142 clinical specimens (78 urine, 19 oral fluid and 45 sera) related to 97 suspected cases, were sent to LRR01 for laboratory diagnosis and genotyping of MV (Table 1) . For each patient, personal data, vaccination status information, time of rash onset and the LHA where the case was reported, were provided in a patient information form sent with the specimens.
Furthermore, for cases reported in the LHA of Bologna, organized in 6 health districts (HDs), additional epidemiological and clinical data were obtained from the database of each HD (6) . According to the 2012 European Commission case definition, the notified suspected cases were classified as confirmed, probable or possible (9) .
Laboratory methods
Serological test
Serum specimens were tested by an automated chemiluminescence immunoassay, LIAISON ® measles IgM/IgG (DiaSorin, Italy), for the detection of MV-IgM and IgG, following the manufacturer's instructions. According to the integrated surveillance program, the specimens that resulted negative for MV-IgM were tested for RV-IgM and IgG.
Molecular test
The detection of MV-RNA by PCR was performed on urine or oral fluid specimens. The extraction was carried out with the QIAsymphony-SP instrument (Qiagen, USA). Briefly, RNA was purified from 500 μL of urine sediment or 800 μL of oral fluid and eluted in 115 μL and 140 μL, respectively. Reverse transcription of MV-RNA was performed as previously described (21) . For each specimen, 4 µL of cDNA were amplified by multiplex Real-Time PCR for the simultaneous detection of MV-RNA (114 bp, N gene) and RV-RNA (129 bp, P150 gene) using the set of primers and TaqMan probes described by Hubschen et al. (15) .
Sequencing and phylogenetic analysis
For all MV-RNA positive specimens, the MV genome region required for genotype characterization was amplified and sequenced, as previously described (21) . The sequences obtained were aligned by CLUSTAL-W and the genotype was assigned by comparison with WHO reference strains (24) . Sequences, named according to official WHO nomenclature, were sent to NRL for the submission to MeaNs (the Measles Nucleotide Surveillance databank) (24) . The phylogenetic trees were constructed by MEGA (version 7) using neighbor-joining method (22) .
Results
Laboratory confirmation
Among the 101 suspected cases, 72 (71.3%) were confirmed, 5 (5%) were classified as possible, 3 (3%) as probable and 21 (20.7%) were discarded. The 72 confirmed cases were positive by serological and/or molecular methods. Particularly, 11/72 (15.3%) cases were tested only for MV-IgM detection, 34/72 (47.2%) only by molecular method and 27/72 (37.5%) by both methods. Among these, discordant results were obtained in 6/27 (22.2%) cases. One case was negative for MV-IgM and positive for MV-RNA detection. The specimens (serum and urine) were collected within 24 hours after onset of rash. In the remaining 5 cases, positive results were obtained by serological diagnosis and negative by molecular methods. These specimens were collected in a median time equal to 12 days (range: 4-24 days) after onset of rash. In 56/72 (77.7%) cases, MV-RNA was identified in urine/oral fluid specimens and genotyping of MV strains was performed.
Vaccination status, age distribution and complications of confirmed measles cases.
The majority of suspected measles cases was reported during the first 5 months of 2016 ( Figure 1 were unvaccinated and 5 (8.2%) vaccinated with 1 dose. The median age of confirmed cases was 29 years (range: 9 months-68 years) and the highest incidence was found in the age group 15-39 years ( Figure 2 ). Complications were reported in 48/72 (66.6%) cases (Table 2) ; the most frequent were diarrhea and hepatitis.
MV strains identified in ERR outbreaks
Phylogenetic analysis showed two genotypes of MV circulated during 2016: B3 was found in 45 (80.4%) cases and D8 in the remaining 11 (19.6%) .
Sequences belonging to genotype B3 clustered into three main variants. (Figure 3 Neighbour-joining tree for nucleotide sequences of MV strains belonging to genotype B3. Sequences from Bologna clusters: (▲) cluster 1, (•) cluster 3, (○) cluster 2. In brackets are reported the number of identical sequences detected in ERR during 2016. The evolutionary history was inferred by using the Maximum Likelihood method based on the Kimura 2-parameter model. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. Bootstrap values >80% are reported. Evolutionary analyses were conducted in MEGA7. below) and Rimini (n=9). Among the cases confirmed in LHA of Rimini, the 55.5% (5/9) were from the Roma/Sinti population.
For the genotype D8, 4 MV strains were identified. In particular, the sequences found in 7 cases reported in the LHA of Bologna (see below) showed 100% identity with the named strain MVs/Osaka.JPN/29.15/, the same that circulated in Italy and in Europe (Figure 4 ). Two cases were imported from the UK (MVs/Parma.ITA/35.16) and Denmark (MVs/ReggioEmilia. ITA/15.16) and showed 100% identity each other and with the named strain MVs/Cambridge.GBR/5.16. Other one was identified in a patient returning from Austria and belongs to the named variant MVs/Victoria.AUS/6.11; the last was identified in a patient returning from India. The nucleotide analysis showed 100% identity between these latter two sequences and MV strains circulated in visited countries.
Measles clusters identified in the LHA of Bologna
During 2016, 35 suspected measles cases were reported. Five measles clusters were identified in the 6 HDs of the LHA of Bologna ( Figure 5 ), in which confirmed (n=18), probable (n=3) and possible cases (n=2) were involved. In the remaining 16 suspected cases, 6 were classified as sporadic (in 3 cases endemic MV strains were identified), 1 case as imported and 5 were discarded. The first cluster, n.1 (February-March 2016), originated from an unvaccinated infant (18 months old) who was admitted at a local Emergency Department (ED), where the infection was then transmitted to 4 unvaccinated people: 2 infants and 2 adults. Of these, 1 infant and 1 adult were members of the Roma/Sinti community and they transmitted, outside of hospital, the infection to one unvaccinated adult relative. The other infected child was readmitted to the ED where the MV infection was transmitted to two unvaccinated infants. In this cluster, one case was classified as probable, while the remaining 7 were confirmed. The results of genotyping analysis were available for 5 cases, in which the Niger variant of genotype B3 was identified ( Figure 3 ). The identical sequence was detected in another cluster, n. 2 (during March), originated from an unvaccinated adult who transmitted the infection to a family member (a 35 month old child). o n l y which the Niger variant of genotype B3 was identified ( Figure 3 ). The identical sequence was detected in another cluster, n. 2 (duro n l y
The identical sequence was detected in another cluster, n. 2 (during March), originated from an unvaccinated adult who transmito n l y ing March), originated from an unvaccinated adult who transmit-variant was also detected in cluster n. 3 (during July) involving 2 adult siblings (31 and 33 years old). Both showed clinical measles symptoms, after a trip to Calabria (Southern Italian region) where they had contact with a confirmed measles case. Phylogenetic analysis identified the Niger variant of genotype B3, circulating in ERR as well as in Calabria (Figure 3 ). An additional family cluster, n.4 (during August), affected three unvaccinated siblings. The index case was a 15 year old boy returning from the UK. He transmitted the infection to two siblings (12 and 9 years old). The laboratory diagnosis and molecular characterization of MV strain involved was not performed because their parents refused biological specimen collection. Therefore, the index case was classified as a probable imported case and the siblings as possible cases. The last cluster, n.5 (during November), originated from an unvaccinated student (17 years old) that was admitted to a local ED for persistent hyperpyrexia and onset of rash. In the nosocomial setting, 2 adult patients and 3 nurses had direct contact with the index case and developed measles symptoms after 10-15 days. Two of these nurses transmitted the infection to 2 unvaccinated adults outside the hospital. A total of 8 confirmed cases were involved. Results of sequence analysis were available in 5 cases and identified an Italian endemic MV strain of genotype D8 (Figure 4 ). Among the 18 confirmed measles cases reported in the LHA of Bologna, transmission occurred in nosocomial setting for 10 cases (55.5%) and in 3/10 (30%) cases were involved HCWs. As control measures carried out to limit the spread of infection, contacts of confirmed cases were invited to be vaccinated. The measles immunity status of HCWs was verified and MRR vaccine immunization was offered to susceptible individuals.
Discussion
During 2016, a high number of measles cases was reported in the ERR with incidence equal to 1.8/100,000 inhabitants (17) . The 71.3% of suspected cases were confirmed by laboratory diagnosis using molecular and/or serological methods. Among the cases tested by both methods, discordant results were obtained in 22.2% of cases due to the timing of specimen collection (4,16,21,23,) . In the 77.8% of confirmed cases the phylogenetic analysis was performed and results showed the circulation of MV strains belonging to genotype B3 (80.4%) and D8 (19.6%). The data reflect the nationwide MV genotypes circulation during last two years (12, 19, 25) . Three strains of B3 and four of D8 were identified. In 5.4% of cases, strains imported from other countries were found. In the remaining 94.6% of cases, MV strains circulating in Italy were identified, showing the endemic transmission of virus within a population with immunity gaps. In fact, in the ERR, as in other Italian regions, the MMR vaccine coverage was below the target of 95%, which was set to eliminate the endemic transmission of MV (2) . During 2015, in ERR, the coverage for the second dose of MMR was equal to 88.9% in 7 year old children (7) . Among the confirmed cases, for which vaccination status was known, 91.8% were unvaccinated and most of the cases were reported among adults ranging between ages of 15 to 39. As described by other authors, in Italy, in this group the higher number of susceptible individuals is present (19) .
Finally, our data also showed the spread of MV in a nosocomial setting, occurring in 34.7% ( u s e individuals is present (19) .
u s e
Finally, our data also showed the spread of MV in a nosocomiu s e o n l y 95%, which was set to eliminate the endemic transmission of MV o n l y 95%, which was set to eliminate the endemic transmission of MV (2) . During 2015, in ERR, the coverage for the second dose of o n l y (2) . During 2015, in ERR, the coverage for the second dose of MMR was equal to 88.9% in 7 year old children (7) . Among the o n l y MMR was equal to 88.9% in 7 year old children (7) . Among the confirmed cases, for which vaccination status was known, 91.8% o n l y confirmed cases, for which vaccination status was known, 91.8% were unvaccinated and most of the cases were reported among o n l y were unvaccinated and most of the cases were reported among adults ranging between ages of 15 to 39. As described by other o n l y adults ranging between ages of 15 to 39. As described by other authors, in Italy, in this group the higher number of susceptible o n l y authors, in Italy, in this group the higher number of susceptible measles immunization rate remains low among hospital staff, as described by other authors (10, 12, 13, 14) . In fact, this group is considered to be hard-to-reach by immunization programmes, as well as the Roma/Sinti population that were also involved in the 12.5% (9/72) of confirmed cases (8, 22) . The lower vaccination coverage rates in hard-to-reach populations, contribute to the spread of MV and therefore pose a public health concern (8, 10, 13, 14) . It is important to underline that, in ERR, the transmission of measles among HCWs occurred in 20.8% (15/72) of confirmed cases. In fact, HCWs have a higher risk to measles infection than the general population given their greater opportunity for exposure and being a source of infection for their collogues and susceptible patients, including those hospitalised with critical conditions (10, 13, 14) .
Conclusions
In conclusion, MV continues to circulate in ERR and in Italy due to insufficient vaccine coverage. In Italy, much progress has been made through laboratory confirmation and molecular characterization of MV strains that help to identify the sources of virus and allow prompt planning and effective implementation of control measures. In particular, the successful establishment of a National Laboratory Network (MoRoNet) has led to high quality standards in laboratory surveillance. Nevertheless, further efforts will be needed to eliminate the endemic MV transmission, such as improving the vaccine coverage and implementing the immunization activities for all under-vaccinated population groups. 
